Jabez Biosciences is a clinical-stage biotechnology company that is developing small molecule inhibitors for the treatment of both solid and liquid cancers. Our lead drug candidate, JBZ-001, is a small molecule inhibitor of a crucial enzyme involved in the de novo synthesis of pyrimidine nucleotides, DHODH, that displays highly optimized therapeutic qualities.
November, 2026
5
Friday
10:00 AM - 10:45 AM
10:45 AM - 11:30 AM
11:30 AM - 12:15 PM
12:15 PM - 1:00 PM
1:00 PM - 1:45 PM
1:45 PM - 2:30 PM
2:30 PM - 3:15 PM
3:15 PM - 4:00 PM
4:00 PM - 4:45 PM
4:45 PM - 5:30 PM
5:30 PM - 6:15 PM
6:15 PM - 7:00 PM
7:00 PM - 7:45 PM
7:45 PM - 8:30 PM
8:30 PM - 9:15 PM
August 26,2019
Awesome Job!
We have received your appointment and will send you a confirmation to your provided email upon approval.
/ Per Listing
Lorem ipsum dolor sit amet, lorem sit.
/ Per Listing
Lorem ipsum dolor sit amet, lorem sit.
Claim request is processed after verification..